Article Versions Notes

Argyriou E, Nezos A, Roussos P, Venetsanopoulou A, Voulgarelis M, Boki K, Tzioufas AG, Moutsopoulos HM, Mavragani CP. Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3): A Novel Marker for Lymphoma Development among Patients with Young Onset Sjogren’s Syndrome. Journal of Clinical Medicine. 2021; 10(4):644. https://doi.org/10.3390/jcm10040644

Argyriou, Evangelia, Adrianos Nezos, Petros Roussos, Aliki Venetsanopoulou, Michael Voulgarelis, Kyriaki Boki, Athanasios G. Tzioufas, Haralampos M. Moutsopoulos, and Clio P. Mavragani. 2021. "Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3): A Novel Marker for Lymphoma Development among Patients with Young Onset Sjogren’s Syndrome" Journal of Clinical Medicine 10, no. 4: 644. https://doi.org/10.3390/jcm10040644

Argyriou, E., Nezos, A., Roussos, P., Venetsanopoulou, A., Voulgarelis, M., Boki, K., Tzioufas, A. G., Moutsopoulos, H. M., & Mavragani, C. P. (2021). Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3): A Novel Marker for Lymphoma Development among Patients with Young Onset Sjogren’s Syndrome. Journal of Clinical Medicine, 10(4), 644. https://doi.org/10.3390/jcm10040644